Upgrades/Downgrades
Updated: 12-Oct-26 12:05 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Tyler Tech | TYL | Wells Fargo | Equal Weight » Overweight | $400 | |
| Terreno Realty | TRNO | BMO Capital Markets | Market Perform » Outperform | $75 | |
| T-Mobile US | TMUS | Raymond James | Mkt Perform » Outperform | $170 | |
| Sallie Mae | SLM | Morgan Stanley | Equal-Weight » Overweight | $30 | |
| Salesforce | CRM | BofA Securities | Underperform » Buy | $285 | |
| Mattel | MAT | Seaport Research Partners | Neutral » Buy | $20 | |
| Manhattan Assoc | MANH | Morgan Stanley | Equal-Weight » Overweight | $250 | |
| Humana | HUM | Raymond James | Mkt Perform » Outperform | $520 | |
| Hub Group | HUBG | Robert W. Baird | Neutral » Outperform | $29 | |
| Hexcel | HXL | Seaport Research Partners | Neutral » Buy | $104 | |
| First Solar | FSLR | Truist | Hold » Buy | $270 | |
| C3.ai | AI | Northland Capital | Market Perform » Outperform | $16 | |
| Brown & Brown | BRO | Keefe Bruyette | Mkt Perform » Outperform | $77 | |
| Blackstone Digital Infrastructure Trust | BXDC | Citigroup | Neutral » Buy | $20 | |
| Biogen | BIIB | JP Morgan | Neutral » Overweight | $300 | |
| AST SpaceMobile | ASTS | Deutsche Bank | Hold » Buy | $93 | |
| Allstate | ALL | Wells Fargo | Underweight » Equal Weight | $236 | |
| Allison Transmission | ALSN | Citigroup | Neutral » Buy | $135 | |
| BioMarin Pharmaceutical | BMRN | Raymond James | Outperform » Strong Buy | $109 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| UWM Holdings | UWMC | BTIG Research | Buy » Neutral | ||
| Roivant Sciences | ROIV | Wolfe Research | Outperform » Peer Perform | ||
| Monday.com | MNDY | Barclays | Overweight » Equal Weight | $100 | |
| Insmed | INSM | Wolfe Research | Outperform » Peer Perform | ||
| HubSpot | HUBS | Barclays | Overweight » Equal Weight | $240 | |
| GoDaddy | GDDY | RBC Capital Mkts | Outperform » Sector Perform | $95 | |
| Freddie Mac | FMCC | Mizuho | Outperform » Neutral | $4 | |
| Fannie Mae | FNMA | Mizuho | Outperform » Neutral | $5 | |
| Enact Holdings | ACT | JP Morgan | Neutral » Underweight | $44 | |
| The Baldwin Group | BWIN | Keefe Bruyette | Outperform » Mkt Perform | $32.50 | |
| Ally Financial | ALLY | Morgan Stanley | Overweight » Equal-Weight | $43 | |
| Alexandria RE | ARE | BMO Capital Markets | Market Perform » Underperform | $41 | |
| Adobe | ADBE | Wells Fargo | Overweight » Underweight | $225 | |
| C.H. Robinson | CHRW | Deutsche Bank | Buy » Hold | $153 | |
| The Baldwin Group | BWIN | TD Cowen | Buy » Hold | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Vylor | VYLR | UBS | Buy | $89 | |
| Vera Therapeutics | VERA | Leerink Partners | Market Perform | $34 | |
| TeraWulf | WULF | TD Cowen | Buy | $21 | |
| Tectonic Therapeutic | TECX | UBS | Neutral | $26 | |
| Spyre Therapeutics | SYRE | UBS | Buy | $120 | |
| Shattuck Labs | STTK | UBS | Buy | $17 | |
| Robinhood Markets | HOOD | Evercore ISI | Outperform | $130 | |
| Quoin Pharmaceuticals | QNRX | BTIG Research | Buy | $14 | |
| Q32 Bio | QTTB | Leerink Partners | Outperform | $40 | |
| Protagonist Therapeutics | PTGX | UBS | Buy | $184 | |
| Odyssey Therapeutics | ODTX | UBS | Buy | $27 | |
| Ocular Therapeutix | OCUL | UBS | Buy | $14 | |
| Nektar Therapeutics | NKTR | UBS | Neutral | $53 | |
| Nektar Therapeutics | NKTR | Leerink Partners | Outperform | $130 | |
| MiniMed | MMED | Jefferies | Hold | $22 | |
| Mineralys Therapeutics | MLYS | UBS | Neutral | $29 | |
| Kardigan | KARD | UBS | Buy | $25 | |
| Interactive Brokers | IBKR | Evercore ISI | Outperform | $100 | |
| IDEXX Labs | IDXX | KeyBanc Capital Markets | Sector Weight | ||
| Hartford Financial | HIG | Truist | Hold | $137 | |
| First Financial | THFF | Hovde Group | Outperform | $85 | |
| Evommune | EVMN | UBS | Neutral | $8 | |
| Charles Schwab | SCHW | Evercore ISI | In-line | $107 | |
| Butterfly Network | BFLY | Canaccord Genuity | Buy | $10 | |
| BioAge Labs | BIOA | UBS | Neutral | $8 | |
| Beta Bionics | BBNX | Jefferies | Buy | $30 | |
| AxoGen | AXGN | BofA Securities | Buy | $52 | |
| American Savings Bank, N.A. | ASBH | Piper Sandler | Overweight | $20 | |
| American Savings Bank, N.A. | ASBH | Keefe Bruyette | Mkt Perform | $19 | |
| American Savings Bank, N.A. | ASBH | DA Davidson | Buy | $20 | |
| AbCellera Biologics | ABCL | UBS | Buy | $18 | |
| EVA Live | GOAI | Maxim Group | Buy | $7 | |
| Everspin Technologies | MRAM | Maxim Group | Buy | $25 | |
| Hemab Therapeutics Holdings | COAG | Rodman & Renshaw | Buy | $56 | |
| American Savings Bank, N.A. | ASBH | Stephens | Overweight | $21 | |
| Melco Resorts & Entertainment | MLCO | Citigroup | Buy | $9.40 | |
| Las Vegas Sands | LVS | Citigroup | Buy | $71.50 | |
| Interactive Brokers | IBKR | Deutsche Bank | Buy | $102 | |
| Chemung Financial | CHMG | Hovde Group | Market Perform | $88 | |
| Amrize | AMRZ | Longbow | Buy | ||
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Equillium | EQ | Leerink Partners | Outperform | $6 | |
| Connect Biopharma | CNTB | Leerink Partners | Outperform | $4 | |
| American Bitcoin Corp. | ABTC | H.C. Wainwright | Buy | $22 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |